Opiate compounds, methods of making and methods of use

Details Opiate compounds, methods of making and methods of use Opiate compounds, methods of making and methods of use

2005-05-31

2005-05-31

Aulakh, Charanjit S. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S223000, C546S224000

Reexamination Certificate

active

06900228

ABSTRACT:
The present application relates to novel opioid receptor antagonists and agonists, methods of making these compounds, and methods of use thereof.

REFERENCES:
patent: 2683714 (1954-07-01), Kallischnigg
patent: 2683715 (1954-07-01), Kallischnigg
patent: 3531487 (1970-09-01), Berger et al.
patent: 3678057 (1972-07-01), Ebnother et al.
patent: 3821231 (1974-06-01), Lavrinovich et al.
patent: 3978222 (1976-08-01), Enders et al.
patent: 4022792 (1977-05-01), Albertson et al.
patent: 4278797 (1981-07-01), Zimmerman
patent: 4289882 (1981-09-01), Rapoport et al.
patent: 4372975 (1983-02-01), Mouzin et al.
patent: 4419517 (1983-12-01), Brittelli et al.
patent: 4678791 (1987-07-01), Napier et al.
patent: 4816586 (1989-03-01), Portoghese
patent: RE33495 (1990-12-01), Kudzma et al.
patent: 5039681 (1991-08-01), Sugimoto et al.
patent: 5091393 (1992-02-01), Den Hartog et al.
patent: 5128118 (1992-07-01), Carroll et al.
patent: 5141959 (1992-08-01), Carroll et al.
patent: 5159081 (1992-10-01), Cantrell et al.
patent: 5162335 (1992-11-01), Vandewalle et al.
patent: 5214148 (1993-05-01), Feldman et al.
patent: 5250542 (1993-10-01), Cantrell et al.
patent: 5270328 (1993-12-01), Cantrell et al.
patent: 5298499 (1994-03-01), Carroll et al.
patent: 5319084 (1994-06-01), Cook et al.
patent: 5319087 (1994-06-01), Zimmerman et al.
patent: 5380848 (1995-01-01), Kuhar et al.
patent: 5413779 (1995-05-01), Kuhar et al.
patent: 5457208 (1995-10-01), Portoghese et al.
patent: 5496953 (1996-03-01), Kuhar et al.
patent: 5637701 (1997-06-01), Ashwell
patent: 5736123 (1998-04-01), Carroll
patent: 5831095 (1998-11-01), Gonzalez et al.
patent: 5854249 (1998-12-01), Chang et al.
patent: 5935953 (1999-08-01), Kuhar et al.
patent: 6046200 (2000-04-01), Tortella et al.
patent: 6123917 (2000-09-01), Carroll
patent: 6153626 (2000-11-01), Pelcman et al.
patent: 6436959 (2002-08-01), Carson et al.
patent: 0 018 077 (1980-10-01), None
patent: 4-275288 (1992-09-01), None
patent: WO 93/15062 (1993-08-01), None
patent: WO 98/28269 (1998-07-01), None
patent: WO 98/28270 (1998-07-01), None
patent: WO 99/33806 (1999-07-01), None
patent: WO 99/45925 (1999-09-01), None
patent: WO 01/44243 (2001-06-01), None
XP-002203669, Bertha et al., “A Marked Change of Receptor Affinity of the 2-Methyl-5-(3-Hydroxyphenyl)Morphans Upon Attachment of an (E)-8-Benzyliden Moiety: Synthesis and Evaluation of a New Class of O'Receptor Ligands”, Journal of Medicinal Chemistry, vol. 37, No. 19, 1994, pp. 3163-3170.
XP-002203670, Ong et al., “Phenylmorphan Agonists-Antagonist”, Journal of Medicinal Chemistry, vol. 17, No. 1, 1974, pp. 133-134.
U. S. Provisional Appl. No. 60/068,794, filed Dec. 24, 1997.
Thomas et al., “A Stereoselective Syynthetic Approach to N-Alkyl-4beta-methyl-5-phenyl morphans” Tetrahedron Letters, Elsevier Science Publishers, Amsterdam, NL, vol. 40, No. 3, Jan. 15, 1999, pp. 403-406.
Thomas et al., “N-substituted 9.beta.-Methyl-5-(3-hydroxyphenyl)morphans Are Opioid Receptor Pure Antagonists”, Journal of Medicinal Chemistry, vo. 41, No. 21, 1998, pp. 4143-4149.
Calderon et al., “Probes for narcotic receptor Mediated Phenomena. 19. Synthesis of (1)-4[(.alpha.R)-.alpha.((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective Nonpeptide .delta. Opioid Receptor Agonist”, Journal of Medicinal Chemistry, vol. 37, No. 14, 1994, pp. 2125-2128.
Thomas et al., “Optically Pure (0)-4-[(N-Allyl-3-Methyl-4-Piperidinyl)Phenylamino]-N, N-Diethylbenzamide Displays for the delta Opioid Receptor”, Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 9, No. 23, Dec. 6, 1999, pp 3347-3350.
Froimowitz et al., “Phenylmorphans and Analogues: Opioid Receptor Subtype Selectivity and Effect of Conformation in Activity”, Journal of Medicinal Chemistry, vol. 35, No. 9, 1992, pp. 1521-1525.
Bertha et al., “Probes for arcotic Receptor-Mediated Phenomena. 20. Alteration of Opioid Receptor Subtype Selectivity of the t-(3-Hydroxyphenyl)morphans by Application of the Message-Address Concept: Preparation of .delta.-Opioid Receptor Ligands”, Journal of Medicinal Chemistry, vol. 38, No. 9, 1995, pp. 1523-1537.
Bertha et al., “A Marked Change of Receptor Affinity of the 2-Methyl-5-(e-hydroxyphenyl)morphans upon Attachment of an (E)-8-Benzylidene Moiety: Synthesis and Evaluation of a New Class of .sigma. Receptor Ligands”, Journal of Medicinal Chemistry, vol. 37, No. 19, 1994, pp. 3163-3170.
Ong, et al., “Phenylmorphan Agonists-Antagonists” Journal of Medicinal Chemistry, vol. 17, No. 1, 1974, pp. 133-134.
Thomas, J.B.; Mascarella, S.W.; Rothman, R.B.; Partilla, J.S.; Xu, H.; McCullough, K.B.; Dersch, C.M.; Cantrell, B.E.; Zimmerman, D.M.; Carroll, F.I. Investigation of the N-Substituent Conformation Governing Potency and M Receptor Subtype-Selectivity in (+)-(3R,4R)-Dimethyl-4-(3-Hydroxyphenyl)Piperidine Opioid Antagonists,J. Med. Chem.1998, 41(11), 1980-1990.
Thomas, J.B.; Zheng, X.; Brieaddy, L.E.; Burgess, J.P.; Mascarella, S.W.; Fix, S.E.; Cantrell, B.E.; Zimmerman, D.M.; Carroll, F.I., Synthesis of 9B-Methyl-2-Alkyl-7-Oxo-5-Arylmorphans,Tetrahedron Letters, V. 39, 7001-7004 (1998).
Thomas, J.B.; Zheng, X.; Mascarella, S.W.; Rothman, R.B.; Dersch, C.M.; Partilla, J.S.; Flippen-Anderson, J.L; George, C.F.; Cantrell, B.E.; Zimmerman, D.M.; Carroll, F.I., N-Substituted 9B-Methyl-5-3(Hydroxyphenyl)Morphans are Opioid Receptor Pure Antagonists.J. Med. Chem.1998, 41(21), 4143-4149.
Thomas, J.B.; Mascarella, S. W.; Burgess, J.P.; Xu, H.; McCullough, K.B.; Rothman, R.B.; Flippen-Anderson, J.L.; George, C.F.; Cantrell, B.E.; Zimmerman, D.M.; Carroll, F.I., N-Substituted Octahydro-4A-(3-Hydroxyphenyl)-10A-Methylbenzo[G]Isoquinolines are Opioid Receptor Pure Antagonists,Bioorganic&Medicinal Chemistry Letters 8(1998) 3149-3152.
Thomas, J.B.; Gigstad, K.M.; Fix, S.E.; Burgess, J.P.; Cooper, J.B.; Mascarella, S.W.; Cantrell, B.E.; Zimmerman, D.M.; Carroll, F.I., A Stereoselective Synthetic Approach to N-Alkyl-4-B-Methyl-5-Phenylmorphans,Tetrahedron Letters, V. 40, 403-406 (1999).
Thomas, J.B.; Fall, M.J.; Cooper, J.B.; Rothman, R.B.; Mascarella, S.W.; Xu, Heng; Partilla, J.S.; Dersch, C.M.; McCullough, K.B.; Cantrell, B.E.; Zimmerman, D.M.; Carroll, F.I.; Identification of an Opioid Receptor Subtype-Selective N-Substituent for (+)-(3R,4R)-Dimethyl-4-(3-Hydroxyphenyl)Piperidine,J. Med. Chem.1998, 41(26), 5188-5197.
Thomas, J.B.; Atkinson, R.N.; Herault, X.M.; Rothman, R.B.; Mascarella, S.W.; Dersch, C.M.; Xu, H.; Burgess, J.P.; Carroll F.I., (+)-4-[(N-Allyl-Cis-3-Methyl-4-Piperidinyl)Phenylamino]-N,N-Diethylbenzamide Displays Selective Binding for the Delta Opioid Receptor,Bioorganic&Medicinal Chemistry Letters, 1999, 9, 3053-3056.
Thomas, J.B.; Atkinson, R. N.; Herault, X. M.; Rothman, R. B.; Mascarella, S. W.; Dersch, C. M.; Xu, H.; Horel, R. B.; Carroll, F. I., Optically Pure(−)-4-[(N-Allyl-3-Methyl-4-Piperidinyl)Phenyl-Amino]-N,N-Diethylbenzamide Displays Selective Binding and Full Agonist Activity for the δ Opioid Receptor,Bioorg. Med. Chem. Lett.1999, 9, 3347-3350.
Thomas, J.B.; Atkinson, R.N.; Rothman, R.B.; Burgess, J.P.; Mascarella, S.W.; Dersch, C.M.; Xu, H.; Carroll, F.I., 4-8-[Alkyl-8-Azabicyclo[3.2.1]Octyl-3-YL)-3-Arylanilino]-N,N-Diethylbenzamides: High Affinity, Selective Ligands for the Delta Opioid Receptor Illustrate Factors Important to Antagonist Activity,Bioorganic&Medicinal Chemistry Letters10 (2000) 1281-1284.
Partilla, J.S.; Carroll, F. I.; Thomas, J.B.; Rice, K.C.; Zimmerman, D.M.; Rothman, R.B., Opioid Peptide Receptor Studies. 13, Characterization of Opioid Antagonists with the [35S]GTPy-S Binding Assay,Analgesia, vol. 4, pp. 27-32, 1999.
Chang, K. J.; Rigdon, G. C.; Howard, J. L.; McNutt, R. W. A Novel, Potent and Selective Nonpeptidic Delta Opioid Receptor Agonist BW373U86,J. Pharm. Exp. Ther.1993, 267, 852-857.
Calderon, S. N.; Rothman, R. B.; Porreca, F.; Flippen-Anderson, J. L.; McNutt, R. W.; Xu, H.; Smith, L. E.; B

Affiliated with

Also associated with

Rating

Opiate compounds, methods of making and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Opiate compounds, methods of making and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opiate compounds, methods of making and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3443663